Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124301) titled 'Observation on the efficacy of recombinant human growth hormone combined with low-dose oral estrogen in the treatment of prepubertal Turner syndrome' on May 10.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Chengdu Women's and Children's Central Hospital

Condition: Turner's syndrome

Intervention: Group treated with growth hormone alone:Subcutaneous injection of growth hormone alone

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-05-13

Target Sample Size: Group treated with growth hormone alone:5;Growth hormone combined with low-dose ...